Andrea S. James - 26 Mar 2025 Form 4 Insider Report for Oncocyte Corp (OCX)

Role
Chief Financial Officer
Signature
/s/ Andrea James
Issuer symbol
OCX
Transactions as of
26 Mar 2025
Net transactions value
$0
Form type
4
Filing time
28 Mar 2025, 16:05:18 UTC
Previous filing
11 Feb 2025
Next filing
30 Sep 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCX Restricted Stock Units Award $0 +113,207 $0.000000 113,207 26 Mar 2025 Common Stock 113,207 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the restricted stock units will vest on each of the one-, two-, three- and four-year anniversaries, respectively, of the effective date of grant subject to continuous service through the applicable vesting date.